Oscar (OSCR) Soars 22% in Potential ACA Extension

Group 1 - Oscar Health Inc. (NYSE:OSCR) experienced a significant stock price increase of 22.33%, closing at $16.49, following reports of a potential two-year extension of the Affordable Care Act (ACA) by President Trump [1][3] - The ACA extension could stabilize the insurance market and help companies like Oscar maintain lower premium offerings, which is crucial as insurance premiums for approximately 22 million Americans are projected to more than double without the ACA [3] - Oscar Health reported a widening net loss of $137 million in Q3, a 152% increase from a loss of $54.60 million in the same period last year, while revenues rose by 23% to $2.98 billion, up from $2.42 billion, driven by higher membership [4]